1 TAMSULOSIN HCL | 390 of 4920 | 2740 prescriptions Less than 1% of all prescriptions | 2090 | 900 patients 25% of all patients | 700 patients 20% of all patients | |
2 FINASTERIDE | 440 of 1800 | 1090 prescriptions Less than 1% of all prescriptions | | 310 patients 9% of all patients | < 11 | |
3 OXYBUTYNIN CHLORIDE | 90 of 720 | 690 prescriptions Less than 1% of all prescriptions | 390 | 290 patients 8% of all patients | < 11 | |
4 OXYBUTYNIN CHLORIDE ER (OXYBUTYNIN CHLORIDE) | 690 of 1480 | 350 prescriptions Less than 1% of all prescriptions | 210 | 170 patients 5% of all patients | < 11 | |
5 MYRBETRIQ (MIRABEGRON) | 680 of 790 | 350 prescriptions Less than 1% of all prescriptions | | 150 patients 4% of all patients | < 11 | |
6 ALFUZOSIN HCL ER (ALFUZOSIN HCL) | 410 of 140 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
7 CIPROFLOXACIN HCL | 110 of 2740 | 950 prescriptions Less than 1% of all prescriptions | 800 | 830 patients 23% of all patients | 700 patients 20% of all patients | A |
8 SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE/TRIMETHOPRIM) | 300 of 2400 | 800 prescriptions Less than 1% of all prescriptions | 660 | 700 patients 20% of all patients | 580 patients 16% of all patients | A |
9 METHENAMINE HIPPURATE | 350 of 400 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
10 NITROFURANTOIN MONO-MACRO (NITROFURANTOIN MONOHYD/M-CRYST) | 390 of 2520 | 340 prescriptions Less than 1% of all prescriptions | | 280 patients 8% of all patients | < 11 | A |
11 LEVOFLOXACIN | 410 of 1900 | 240 prescriptions Less than 1% of all prescriptions | | 130 patients 4% of all patients | < 11 | A |
12 PHENAZOPYRIDINE HCL | 10 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
13 AMPICILLIN TRIHYDRATE | 30 of 40 | 170 prescriptions Less than 1% of all prescriptions | 170 | 170 patients 5% of all patients | 170 patients 5% of all patients | A |
14 CEPHALEXIN | 580 of 2750 | 310 prescriptions Less than 1% of all prescriptions | | 290 patients 8% of all patients | < 11 | A |